Yahoo Web Search

Search results

1. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 3 hours ago

     CHS-114 shown to have an acceptable safety profile with no dose-limiting toxicities (DLTs) in heavily pretreated patients with solid tumors Selective depletion of peripheral CCR8+ regulatory T cells (Tregs) was observed and depletion was maintained

2. • Small Business - Shelby County Reporter | Shelby County Reporter

     The Shelby County Reporter· 4 hours ago

     Preliminary data from CLN-619 in combination with checkpoint inhibitor pembrolizumab show objective responses in patients with tumor types that are typically unresponsive to pembrolizumab, such ...

3. • 

     Signs and Symptoms of Adrenal Cancer

     Health via Yahoo News· 2 days ago

     However, adrenal carcinoma can also cause additional symptoms such as: Weight loss Decreased appetite Abdominal or flank pain Enlargement of veins in the...

4. • 

     Lung cancer: Pre- and postsurgical immunotherapy may improve outcomes

     Medical News Today· 2 days ago

     Lung cancer is a major cause of all cancer-related deaths, with some treatment options involving...

5. • 

     Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo

     Zacks via Yahoo Finance· 1 day ago

     Per BMY, this...phase III study of the subcutaneous formulation of nivolumab to evaluate and...

6. • OncoHost to Present Poster Demonstrating PROphet®'s Application in Multiple Cancer Indications at...

     FOX21 Colorado Springs· 5 hours ago

     OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced that it has been accepted for a poster presentation at the upcoming ...

7. • 

     Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise

     Newswise· 21 hours ago

     Clinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...

8. • Tumor mutations may not predict response to immunotherapy, study finds

     Medical Xpress· 11 hours ago

     The findings, published in Nature Cancer, upend long-held conventional wisdom and could lead to more effective ways of deciding which patients will benefit most from this type of treatment.

9. • 

     Ipilimumab, a Pioneer Breakthrough in Cancer Treatment

     Forbes· 4 days ago

     In 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...

10. • 

      Immutep shares gain as CapitalOne sets $10 target on cancer drug potential By Investing.com

      Investing.com· 6 days ago

      Efti is under evaluation in combination with standard of care therapies for various cancers,...